- Abiraterone
- Ablation
- Active Surveillance
- Adjuvant Therapy
- Adrenal Gland
- Analog
- Androgen
- androgen
- Anti-androgen
- Anti-androgen withdrawal response
- Benign
- Benign Prostatic Hyperplasia
- Bilateral
- Biomarker
- Biopsy
- Bone scan
- BPH
- Brachytherapy
- BRCA
- Cabazitaxel (JEVTANA)
- Circulating tumor cell (CTC)
- Degarelix
- Denosumab (Prolia, Xgeva)
- Deoxyribonucleic acid (DNA)
- Diethylstilbestrol (DES)
- Differentiation
- Digital Rectal Examination (DRE)
- Dihydrotestosterone (DHT)
- Docetaxel (TAXOTERE)
- Double-blind, Double-blinded:
- Downsizing, Downstaging
- Duct
- Dysplasia
- EBR, EBRT
- Endorectal
- Endorectal ultrasound (ERUS)
- Enzalutamide (Xytiga)
- Epithelium
- erectile dysfunction (ED)
- EXBT, EXRT
- External beam radiation
- Finasteride
- fine-needle aspiration
- Flare
- Flutamide
- free PSA (fPSA)
- Gastrointestinal (GI)
- Gene
- Gland
- Glandular
- gleason
- Gonadotropin-releasing hormone (GnRH)
- Gonads
- Goserelin
- Goserelin acetate
- Grade
- Grading
- High-dose-rate (HDR)
- High-dose-rate remote brachytherapy
- Histology
- Hormonal therapy
- Hormone
- Hormone antagonists
- Hormone refractory prostate cancer (HRPC)
- HRPC: Hormone refractory prostate cancer
- Hyperplasia
- Hypertrophy
- IAS
- ICHT
- IHT
- Immunoassay
- Immunotherapy
- Impotency
- Incontinence
- Insulin
- Intensity modulated radiation therapy (IMRT)
- Interstitial
- Interstitial radiation therapy (IRT)
- Intraductal carcinoma
- Intraepithelial
- Ipilimumab (YERVOY)
- Jewett staging system
- Laparoscopy
- Leuprolide (Lupron)
- Libido
- Luteinizing hormone (LH)
- Lymph
- Lymph Gland
- Lymph nodes
- Lymphatic system
- Lymphocyte
- Magnetic resonance imaging (MRI)
- Malignant
- Metastasis
- Morbidity
- Neoadjuvant
- Neoplasia
- Nerve sparing
- Non-steroidal anti-inflammatory drug (NSAID)
- Norwood scale
- Oncologist
- Orchiectomy
- Osteoporosis
- Palliative
- Palliative care
- Palpable
- Partin Tables
- Pathologist
- Patient-controlled analgesia (PCA)
- PCa
- Phase I trial
- Phase II trial
- Phase III trial
- Phase IV trial
- Placebo
- Progesterone
- Prognosis
- Progression
- Proscar
- Prostascint scan
- Prostate gland
- Prostatectomy
- Prostatic
- Prostatic acid phosphatase (PAP)
- Proton therapy
- PSA
- Radiation Therapy (radiotherapy)
- Radical prostatectomy
- Radiography
- Radiolabeled
- Radium - 233 (Xofigo)
- Red blood cell (RBC)
- Refractory
- Regression
- Remission
- Resection
- Resectoscope
- Retention of urine
- Screening
- Seed, Seeding
- SEER
- Seminal vesicle
- Side Effect
- Sipuleucel-T (PROVENGE)
- SPINK1
- Stage, Staging
- TNM staging system
- Tomography
- Transrectal ultrasound (TRUS)
- Transurethral prostatectomy
- Transurethral resection (TUR)
- Tumor
- Ultrasound (US)
- Ureter
- Urethra
- urologist
- Watchful Waiting (WW)
- Whitmore-Jewett staging system
- Zoladex
- Zoledronic acid (Zometa)